Full-Time

Computational Scientist

Signal Processing

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology company creating transformative health solutions

No salary listed

Senior

Cambridge, MA, USA

Category
Applied Machine Learning
Deep Learning
AI & Machine Learning
Required Skills
Python
Tensorflow
Pytorch
Machine Learning
Pandas
NumPy
C/C++
Data Analysis
Requirements
  • PhD in Electrical/Computer Engineering, Computational Biology, Computational Science, or related field, or Master’s with 5+ years industry experience.
  • Experience developing signal processing and machine learning algorithms for time-series data (electrophysiological, neuro, audio, sequencing, etc)
  • Proficiency in Python and scientific computing libraries (NumPy, SciPy, Pandas, PyTorch or TensorFlow), and C/C++ for algorithm development and data analysis
  • Proven experience in analyzing time-series data, statistical learning, and algorithm design
  • Comfort in high-ambiguity R&D environments and experience prototyping algorithms from scratch
Responsibilities
  • Signal processing methods for high-frequency (kHz) time-series signal data
  • ML models for interpreting and classifying signals
  • Algorithms for handling variable-length, noisy, high-throughput data streams
  • Statistical frameworks to benchmark and validate model and algorithm performance
  • Tools and scripts for managing and analyzing large experimental datasets
Desired Qualifications
  • 2+ years experience in industry setting
  • Previous experience with interpreting sequencing data, and applying base-calling algorithms
  • Familiarity with cloud-native workflows (e.g., AWS S3) and large-scale data infrastructure to store, manage, and analyze large experimental datasets

Flagship Pioneering focuses on creating and developing biotechnology companies that aim to produce significant advancements in human health and sustainability. The company operates by inventing platform companies, which are designed to generate multiple products that can transform various aspects of health and environmental sustainability. Flagship has successfully launched over 100 scientific ventures since its inception in 2000, and currently manages a diverse ecosystem of more than 40 companies, including notable names like Denali Therapeutics and Indigo Agriculture. What sets Flagship apart from its competitors is its unique approach to fostering a wide range of companies under one umbrella, allowing for collaboration and shared resources. The primary goal of Flagship Pioneering is to drive innovation in biotechnology to improve health outcomes and promote sustainable practices.

Company Size

201-500

Company Stage

N/A

Total Funding

$10.5B

Headquarters

Cambridge, Maryland

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Etiome's launch with $50M aims to redefine disease progression detection.
  • Lila Sciences, backed by $200M, automates scientific discovery with AI and robotics.
  • Collaboration with Cambridge University Health Partners accelerates biotech research and innovation.

What critics are saying

  • Increased competition in AI-driven discovery may lead to market saturation.
  • Over-reliance on partnerships could cause strategic misalignments or dependency issues.
  • Rapid technological advancements may challenge Flagship's ability to maintain a competitive edge.

What makes Flagship Pioneering unique

  • Flagship Pioneering creates first-in-category ventures transforming health and sustainability.
  • The company combines innovative capacity with entrepreneurial leadership and capital management.
  • Flagship Pioneering systematically produces pioneering companies through an evolutionary methodology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Flexible Work Hours

Company News

VC News Daily
Apr 25th, 2025
Etiome Launches With $50M

CAMBRIDGE, MA, Etiome has announced a $50 million financing round from Flagship Pioneering.

Venture Capital
Apr 25th, 2025
Flagship Pioneering Unveils Etiome to Redefine Disease Progression Detection

Flagship Pioneering unveils Etiome to redefine disease progression detection.

Health Technology Insights
Apr 24th, 2025
Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare

Flagship Pioneering, the bioplatform innovation company, unveiled Etiome, a company redefining how Health Technology Insights.

GlobeNewswire
Mar 19th, 2025
Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements

$65 million in Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly & Company Two lead programs in...

BioPharmaTrend
Mar 11th, 2025
Lila Sciences Raises $200M to Automate Scientific Discovery with AI and Robotics

Flagship Pioneering has announced the launch of Lila Sciences, a company developing an AI-based platform designed to automate scientific experimentation and discovery.